Course Description:  BCG-unresponsive non–muscle invasive bladder cancer (NMIBC) poses one of the most difficult challenges in urologic oncology, especially for elderly and frail patients. While radical cystectomy remains the gold standard, the treatment landscape is rapidly evolving with innovative bladder-sparing therapies that offer new hope. At the forefront of these advances is TAR-200, an intravesical…